The DSM-IV-Based Generalized Anxiety Disorder Severity Scale
| Autor: | Soraya Seedat, Dylan S. Fincham, Antti Ahokas, Christian de Bodinat, Dan J. Stein |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
medicine.medical_specialty
Generalized anxiety disorder Concurrent validity Reproducibility of Results Construct validity Test validity medicine.disease Anxiety Disorders Severity of Illness Index Antidepressive Agents Diagnostic and Statistical Manual of Mental Disorders Psychiatry and Mental health Convergent validity Surveys and Questionnaires Acetamides medicine Clinical Global Impression Humans Hypnotics and Sedatives Agomelatine Psychiatry Psychology Anxiety disorder medicine.drug Clinical psychology |
| Zdroj: | Journal of Nervous & Mental Disease. 197:391-394 |
| ISSN: | 0022-3018 |
| DOI: | 10.1097/nmd.0b013e3181a77152 |
| Popis: | Currently available symptom severity measures for Generalized Anxiety Disorder (GAD) are not optimal. This study investigates the reliability and validity of a new measure for GAD. The Generalized Anxiety Disorder Severity Scale (DGSS), comprising 8 DSM-IV GAD symptoms assessed in terms of frequency and intensity, was used in a trial of agomelatine versus placebo for the treatment of GAD. Internal reliability, concurrent validity, responsiveness to change, most robust items, and factor structure were computed. The DGSS demonstrated good internal reliability, correlated significantly with the Hamilton Anxiety Scale and Clinical Global Impression severity scale, and demonstrated a clear change in response to agomelatine. The most robust DGSS items were derived, and an exploratory factor analysis yielded a 2-factor structure of the DGSS. The DGSS is potentially a useful scale for the assessment of GAD in clinical trials of this disorder. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|